Category: Forbes

Artificial intelligence and virtual reality technologies have the potential to fundamentally alter both daily living and business operations. Members of Forbes Technology Council speculate on where AI and VR may be going in the near future.

Another year, another set of scandals making headlines in American medicine. Dr. Robert Pearl shares his cure for conflicts of interest.

High blood pressure is the silent killer. But it is also harmful to be told you have high blood pressure when you don’t, and to be treated for high blood pressure when that treatment won’t benefit you. Here are several questions to ask your doctor, so …

The fact that plan sponsors may like rebates, as reflected in their supposed preference for rebates over alternatives does not necessarily mean rebating is rational for the plan sponsor, or for society as a whole. It could mean that they’re simply accu…

10x Genomics, a buzzy, closely held genetics startup based in Pleasanton, Calif., is purchasing Stockholm-based Spatial Transcriptomics for an undisclosed sum in a bid to add another type of genetic imaging tool to its fast-growing line of products.

Democrats seem to believe that the cure for every healthcare problem is a bigger dose of government. But the American people have rejected that approach before — and they may do so again.

Kathrin Hamm, founder of weighted bedding company Bearaby, shares how her quest to solve her own sleep struggles led to a game-changing product that’s helping people all over the world sleep better.

A Russian company has published dozens of studies promoting the use of “release-active drugs,” or RADs, for an incredibly wide range of diseases. A new report reveals that RADs don’t actually contain a single molecule of their supposed active ingredients.